Cell Source, Inc. vs Seres Therapeutics, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Cell Source, Inc. and Seres Therapeutics, Inc. are worth about the same: $20 M and $20 M (market caps of Dec 25, 2022 for Cell Source, Inc. and Oct 30, 2026 for Seres Therapeutics, Inc.). Cell Source, Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
- Seres Therapeutics, Inc. made a net profit of $6 M, while Cell Source, Inc. made a net loss of $5 M.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Cell Source, Inc. CLCS | Seres Therapeutics, Inc. MCRB · #24,348 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 2010 |
| Size | ||
| Market cap | $20 M* | $20 M |
| Revenue | — | $1 M |
| Net income | $-5 M | $6 M▲ best |
| Employees | — | 333 |
| Valuation | ||
| P/E ratio | — | 3.5× |
| Price to sales | — | 25.2× |
| Price to book | — | 0.5× |
| Free cash flow yield | — | 4.4% |
| Profitability | ||
| Return on equity | — | 19.7% |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Dec 2022; ratios FY2024 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Cell Source, Inc. or Seres Therapeutics, Inc.?
Cell Source, Inc. and Seres Therapeutics, Inc. are worth about the same: $20 M and $20 M (market caps of Dec 25, 2022 for Cell Source, Inc. and Oct 30, 2026 for Seres Therapeutics, Inc.). Cell Source, Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
Which makes more money, Cell Source, Inc. or Seres Therapeutics, Inc.?
Seres Therapeutics, Inc. made a net profit of $6 M, while Cell Source, Inc. made a net loss of $5 M.